Peptides and Amines in Affective Disorders

  • Annette Gjerris
  • Ole J. Rafaelsen


Modern psychopharmacology gave rise to the amine hypotheses of affective disorders and the search began for amine metabolites that could fulfil our hopes for biological markers of depression and mania.


Affective Disorder Vasoactive Intestinal Polypeptide Biological Psychiatry Endogenous Depression Recovered Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ashcroft, G.W., Crawford, T.B.B., Eccleston, D., Sharman, D.F., MacDougall, E.G., Stanton, J.B., and Binns, O.K., 1966, 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases, Lancet, 11: 1049.CrossRefGoogle Scholar
  2. Ashcroft, G.W., Blackburn, I.M., Eccleston, D., Glen, A.I.M., Hartley, W., Kinloch, N.E., Lonergan, M., Murray, L.G., and Pullar, I.A., 1973, Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Psychol Med, 3: 319.PubMedCrossRefGoogle Scholar
  3. Banki, C.M., Molnar, G., and Vojnik, M., 1981, Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. 2. Psychopathological symptoms. J. Affect Pis, 3: 91.CrossRefGoogle Scholar
  4. Christensen, N.J., Vestergaard, P., Sorensen, T., and Rafaelsen, O.J. 1980, Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand, 61: 178.PubMedCrossRefGoogle Scholar
  5. Cowdry, R.W., and Goodwin, F.K., 1981, Biological and physiological predictors of drug response, in: “Handbook of biological psychiatry, part VI”, H.M. van Praag, M.H. Lader, O.J. Rafaelsen, and E.J. Sacher, eds., Marchel Dekker,Inc., New York, Basel.Google Scholar
  6. Gjerris, A., Fahrenkrug, J., Bojholm, S., and Rafaelsen, O.J., 1981a, Vasoactive intestinal polypeptide (VIP) in cerebrospinal fluid in psychiatric disorders, in: “Biological Psychiatry”, C. Perris, G. Struwe, and B. Oansson, eds., Elsevier/North- Holland Biomedical Press, Amsterdam.Google Scholar
  7. Gjerris, A., Jensen, E., Christensen, N.O., and Rafaelsen, O.J., 1981b, Adrenaline and noradrenaline in psychiatric disorders, in: “III World Congress of Biological Psychiatry”, Elsevier/ North-Holland Biomedical Press, Amsterdam.Google Scholar
  8. Gjerris, A., Rafaelsen, O.J., and Christensen, N.J., 1981c, Adrenaline in endogenous depression, in: “Adrenergic mechanisms in human pathology”, O.J. Christensen, O. Henriksen, and N.A. Lassen, eds., Clin Psychiol, Suppl. 1: 98.Google Scholar
  9. Gjerris, A., Barry, D.I., Christensen, N.J., and Rafaelsen, O.J., 1983 to be published, MAO-inhibitors revisited I: Adrenaline (A) and noradrenaline (NA) in cerebrospinal fluid (CSF) in isocarboxazide treated rats.Google Scholar
  10. Hökfelt, T., Johansson, O., Ljungdahl, Ä., Lundberg, J.M., and Schultzberg, M., 1980, Peptidergic neurones, Nature, 284:515.PubMedCrossRefGoogle Scholar
  11. Johansson, B.B., Fahrenkrug, J., Wikkelso, C., Andersen, O., and Blomstrand, C., 1982, Vasoactive intestinal polypeptide in human cerebrospinal fluid, Front Horm Res, 9: 189.Google Scholar
  12. Lingjaerde, O., 1983, The biochemistry of depression. A survey of monoaminergic, neuroendocrinological, and biorhythmic disturbances in endogenous depression, Acta Psychiatr Scand, Suppl. 302: 36.CrossRefGoogle Scholar
  13. Maas, J.W., Koscis, J.H., Bowden, C.L., Davis, J.M., Redmond, D.E., Hanin, J., and Robins, E., 1982, Pretreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment, Psychol Med, 12: 37.PubMedCrossRefGoogle Scholar
  14. Rafaelsen, O.J., 1980, Biology of manic-melancholic disorders. Med J Aust, 1: 637.PubMedGoogle Scholar
  15. van Kammen, D.P., Sternberg, D.E., Lake, C.R., and Lerner, P., 1982, Methodological issues in spinal fluid studies of schizophrenia: The case of norepinephrine and dopamine-ß-hydroxylase, Front Horm Res, 9: 198.Google Scholar
  16. van Praag, H.M., 1982, Neurotransmitters and CNS disease. Depression Lancet, ii: 1259.Google Scholar
  17. Vestergaard, P., Sorensen, R., Hoppe, E., Rafaelsen, O.J., Yates, C.M., and Nicolaou, N., 1978, Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders, Acta Psychiatr Scand, 58: 88.PubMedCrossRefGoogle Scholar
  18. Träskman, L., Asberg, M., and Bertilsson, L., 1980, Serotonin and noradrenaline uptake inhibitors in the treatment of depression relationship to 5-HIAA in spinal fluid,: “Recent advances in the treatment of depression”, Proceedings of an international symposium, Corfu, Greece, Munksgaard, Copenhagen.Google Scholar
  19. Ågren, H., 1981, Biological markers in major depressive disorders. A clinical and multivariate study. Acta Universitatis Upsaliensis, Abstr. No. 405.Google Scholar
  20. Åsberg, M., Bertilsson, L., Rydin, E., Schalling, D., Thoren, P., and Träskman, L., 1981, Monoamine metabolites in cerebrospinal fluid in relation to depressive illness, suicidal behaviour and personality, in: “Recent advances in neuropsychopharmacology”, B. Amgrist, G.D. Burrows, M. Lader, O. Lingjaerde, G. Sedvall, and D. Wheatley, eds., Pergamon Press, Oxford.Google Scholar
  21. Åsberg, M., Thoren, P., Träskman, L., Bertilsson, L., and Ringberger V., 1976a, “Serotonin depression” — A biochemical subgroup within the affective disorders? Science, 191: 478.PubMedCrossRefGoogle Scholar
  22. Åsberg, M., Träskman, L., and Thoren, P., 1976b), 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry, 33: 1193, 78.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Annette Gjerris
    • 1
  • Ole J. Rafaelsen
    • 1
  1. 1.Department of Psychiatry RigshospitaletPsychochemistry InstituteCopenhagenDenmark

Personalised recommendations